Use of <i>Ex</i>   <i>Vivo</i> Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for <i>HER2</i> Mutant Non–Small Cell Lung Cancer

Elena V. Ivanova, Pasi A. Jänne, Man Xu et al.|Clinical Cancer Research|2020

Cited by 42